The Citric Acid Cycle: Reactions and Chemistry
A single acetyl group, two carbons stripped from pyruvate, enters a rotating hub of eight reactions. It leaves as two molecules of carbon dioxide. Nothing about this seems dramatic until you notice the bookkeeping. The four-carbon acceptor molecule that receives the acetyl group is regenerated at the end. It remains unconsumed, ready to accept another. This is the chemical logic of a catalytic cycle rather than a linear pathway. It is why the citric acid cycle sits at the center of every aerobic cell's energy economy, plant, fungus, or animal alike. The cycle matters because it is the oxidative clearinghouse for fuel. Carbohydrates, fats, and many amino acids all converge on acetyl-CoA (built via Pyruvate Dehydrogenase and Acetyl-CoA). Acetyl-CoA has essentially one productive fate under aerobic conditions: complete oxidation through this cycle. The four dehydrogenation steps embedded in the eight reactions strip electron pairs. They hand these pairs to NAD⁺ and FAD, generating the reduced carriers NADH and FADH₂. These carriers then feed the Electron-Transport Chain. One substrate-level phosphorylation step generates GTP directly. The cycle is also the biosynthetic quarry from which cells draw carbon skeletons. These skeletons build amino acids, heme, and nucleotides. This is precisely why intermediates must be replenished by Anaplerotic Reactions and Cycle Regulation. The big picture is elegant: two carbons in as acetyl-CoA, two carbons out as CO₂. The oxaloacetate scaffold walks through eight enzyme-catalyzed transformations. These include condensation, isomerization, two oxidative decarboxylations, substrate-level phosphorylation, dehydrogenation, hydration, and a final oxidation. Afterward, it returns to its starting structure. Every step is stereochemically exquisite. The cycle discriminates between chemically identical-looking prochiral faces of citrate with striking precision. This precision puzzled biochemists for years (the "citrate problem," resolved by Ogston's argument about three-point enzyme binding). This article works through all eight reactions mechanistically. It covers the nucleophilic aldol-type condensation that builds citrate. It covers the dehydration–rehydration isomerization to isocitrate. It covers the two NAD⁺-linked oxidative decarboxylations that release the two CO₂ molecules. It covers the substrate-level phosphorylation at succinyl-CoA synthetase. It covers the FAD-linked oxidation embedded in the inner membrane. It covers the hydration of fumarate. It covers the final NAD⁺-linked oxidation regenerating oxaloacetate. We total the yield precisely — 3 NADH, 1 FADH₂, 1 GTP (or ATP), and 2 CO₂ per turn. We derive it from first principles rather than quoting it.
- The cycle oxidizes the two-carbon acetyl group of acetyl-CoA to two CO₂ molecules while regenerating its four-carbon carrier, oxaloacetate.
- Citrate synthase performs a Claisen-type aldol condensation; aconitase then isomerizes citrate to isocitrate via a dehydration/rehydration through cis-aconitate.
- Two oxidative decarboxylations (isocitrate dehydrogenase, α-ketoglutarate dehydrogenase) release both CO₂ and generate 2 NADH per turn.
- Succinyl-CoA synthetase performs the cycle's only substrate-level phosphorylation, generating GTP (or ATP) via a phosphohistidine intermediate.
- Succinate dehydrogenase (Complex II) is FAD-linked and physically embedded in the inner mitochondrial membrane, directly feeding the Electron-Transport Chain.
- One turn nets 3 NADH, 1 FADH₂, 1 GTP/ATP, and 2 CO₂ — energy accounting that underlies the total ATP yield from glucose oxidation.
- Key idea: the cycle is not a pathway that consumes oxaloacetate — it is a catalytic loop that regenerates it, using the acetyl group's carbons purely as the oxidizable fuel.
Where this lives today
The cycle's enzymes are direct drug targets and disease markers. Mutations in succinate dehydrogenase (SDH, Complex II) and fumarase cause hereditary paraganglioma/pheochromocytoma and hereditary leiomyomatosis/renal cell cancer syndromes; the accumulating substrates (succinate, fumarate) act as "oncometabolites" that inhibit α-ketoglutarate-dependent dioxygenases, including the prolyl hydroxylases that normally mark HIF-1α for degradation — succinate/fumarate buildup therefore mimics hypoxia and drives tumor angiogenesis even in normoxic tissue, a mechanism now central to cancer metabolism research. Isocitrate dehydrogenase mutations (IDH1/IDH2), found in a large fraction of gliomas and acute myeloid leukemias, convert the enzyme's activity to produce the oncometabolite 2-hydroxyglutarate instead of α-ketoglutarate, again poisoning dioxygenase-dependent epigenetic regulation; this discovery directly led to the FDA-approved IDH inhibitors ivosidenib and enasidenib. The cycle's intermediates are also biosynthetic starting materials exploited industrially: citrate itself is produced at enormous industrial scale by fermentation of Aspergillus niger for use as a food acidulant and metal chelator (over two million tonnes annually). Succinate is a target "platform chemical" for bio-based plastics and solvents, produced by engineered E. coli and yeast strains that overexpress anaplerotic and cycle enzymes to divert flux toward succinate accumulation. In parasitology, some anthelmintic and antiparasitic drugs exploit differences between the classical aerobic cycle and the fumarate-reductase-driven anaerobic "reverse" segment used by helminths and some protozoa under low-oxygen conditions in host tissue. Understanding the cycle's flux control also underlies clinical management of inherited metabolic disease (e.g., fumarase deficiency, α-ketoglutarate dehydrogenase deficiency causing severe neurological disease) and informs how cells are engineered for metabolic flux analysis using ¹³C-labeled tracers, a direct descendant of the original isotope experiments that resolved the "same two carbons" question.
Ask the tutor: How does the low steady-state concentration of oxaloacetate actually get maintained, and which reactions compete for it?
The physical picture — mechanism through eight active sites
Picture the cycle as a relay of enzyme active sites arranged so that the product of one is precisely the substrate shape required by the next. The mitochondrial matrix holds seven of the eight enzymes as soluble proteins; the eighth, succinate dehydrogenase, is anchored in the inner membrane, its own active site wired directly into the respiratory chain via FAD and iron–sulfur clusters. This physical arrangement is not incidental — it lets electrons flow from succinate to ubiquinone without ever leaving the membrane, and it lets the cycle's other steps release electrons into a diffusible NAD⁺ pool that ferries them separately to Complex I. Mechanistically, the cycle alternates between carbon–carbon bond chemistry (condensation, isomerization, decarboxylation) and redox chemistry (four dehydrogenation events). The condensation step is a carbanion (enolate) attack of acetyl-CoA's methyl carbon on the electrophilic carbonyl of oxaloacetate — chemistry directly analogous to a Claisen condensation, except here it proceeds essentially irreversibly because the high-energy thioester bond is hydrolyzed in the same active site immediately afterward, pulling the equilibrium hard to the right. The two oxidative decarboxylation steps both follow a general pattern: oxidation of a hydroxyl to a ketone generates a β-keto acid, which is intrinsically primed for decarboxylation because the developing carbanion on the departing CO₂ is stabilized by resonance into the newly formed carbonyl. The three-figure sequence below tracks the cycle's carbon skeleton, the stereochemical logic of aconitase's citrate discrimination, and the full energy balance sheet for one turn.
The core ideas — governing relationships
The cycle's net stoichiometry per turn is:
where: the two carbons leaving as CO₂ are not the same two carbons that entered as the acetyl group in that turn — they come from the oxaloacetate-derived carbons, a subtlety verified by isotope labeling and explained by the cycle's own asymmetry at the isocitrate dehydrogenase step (the acetyl-derived carbons are retained through this turn and lost only in a subsequent turn). The free energy driving force for the committed step is the hydrolysis of the citryl-CoA thioester:
where: this large negative value comes from thioester bond hydrolysis coupled to C–C bond formation, making the condensation essentially irreversible in vivo and setting the pace of the entire cycle as its principal flux-control point (together with isocitrate dehydrogenase and α-ketoglutarate dehydrogenase). The energy yield of one full turn, expressed per mole of acetyl-CoA oxidized, using standard reduction potentials for the electron-carrying steps:
where: these potentials set how much free energy is available when electrons are eventually passed to O₂ in the Electron-Transport Chain; the higher (less negative) potential of the succinate–fumarate couple is exactly why FADH₂ enters the chain at Complex II/ubiquinone rather than Complex I, yielding less ATP per pair of electrons than NADH does. The number of ATP equivalents per NADH and FADH₂ oxidized through the respiratory chain (using the modern P/O ratio estimates):
where: 2.5 ATP per NADH and 1.5 ATP per FADH₂ are the contemporary consensus P/O ratios (superseding the older idealized values of 3 and 2), and the final +1 is the GTP generated directly by substrate-level phosphorylation at succinyl-CoA synthetase.
Goal. Show explicitly how acetyl-CoA's methyl group attacks oxaloacetate's carbonyl carbon to build citrate, and how aconitase converts the resulting tertiary alcohol (unable to be oxidized directly) into a secondary alcohol suitable for the next oxidation.
Step 1 (enolization). Citrate synthase first deprotonates the methyl group of acetyl-CoA. The thioester carbonyl strongly acidifies the adjacent C–H bonds (pKa lowered to roughly 20 in solution, far lower in the enzyme's polarized active site) because the resulting carbanion is stabilized by resonance delocalization into the thioester carbonyl, generating an enolate:
An active-site aspartate acts as general base, abstracting the proton; a histidine simultaneously donates a hydrogen bond to the thioester oxygen, stabilizing the developing negative charge — textbook general acid–base catalysis operating in concert.
Step 2 (aldol-type addition). The enolate carbon, now nucleophilic, attacks the electrophilic carbonyl carbon of oxaloacetate. A second active-site histidine protonates the developing oxyanion as the new C–C bond forms, generating citryl-CoA, a tertiary alcohol thioester:
Step 3 (thioester hydrolysis). Without releasing citryl-CoA, the same active site hydrolyzes the thioester bond, releasing free CoA-SH and citrate. This hydrolysis is strongly exergonic (thioester bonds carry roughly −31 kJ/mol of hydrolysis free energy) and is the true source of the large negative ΔG°′ for the overall condensation — it pulls the otherwise reversible aldol addition to completion by Le Chatelier coupling.
Step 4 (why citrate itself cannot be oxidized). Citrate's central carbon bears a tertiary hydroxyl — three carbon substituents and one OH, no H on that carbon. NAD⁺-dependent dehydrogenases oxidize secondary alcohols by hydride transfer from the carbinol C–H to NAD⁺; a tertiary carbon has no such hydride to donate. The cycle therefore cannot directly oxidize citrate and must first relocate the hydroxyl.
Step 5 (aconitase: dehydration). Aconitase, an iron–sulfur (4Fe–4S) enzyme, removes water from citrate across the C2–C3 bond, forming the alkene cis-aconitate. One of the four iron atoms of the cluster, uniquely not ligated by a cysteine, instead binds the substrate's hydroxyl directly — the "Fe–OH" acts as a Lewis acid, facilitating departure of the OH as water while a base removes a proton from the adjacent CH₂ group, in an anti or syn elimination geometry fixed by the enzyme:
Step 6 (aconitase: rehydration). Water is added back across the same double bond, but regiochemically reversed relative to Step 5 — the OH now goes onto what was the terminal carbon rather than the central one, producing isocitrate, in which the hydroxyl now sits on a secondary carbon bearing one hydrogen:
The net transformation, citrate → isocitrate, is chemically an isomerization with equilibrium lying mostly toward citrate (only about 6–7% isocitrate at equilibrium), but the cycle proceeds because the next step consumes isocitrate irreversibly, pulling flux forward by mass action.
Step 7 (the stereochemical resolution). Citrate is prochiral: its central carbon bears two chemically identical –CH₂COO⁻ arms related by a mirror plane, so naive intuition says aconitase should attack them with equal probability, producing a racemic mixture of dehydration products. Experimentally, only one specific stereoisomer of isocitrate is formed. Alexander Ogston resolved this paradox in 1948: an enzyme active site binds a molecule at three points simultaneously, and if those three binding points are not symmetric even when two of the substrate's substituents are, the enzyme can still distinguish the two arms — exactly as a person's left and right hands are distinguishable by a three-point clamp even though a naive two-point comparison might call them identical. This is prochirality selection, and it is why the two acetyl-derived carbons are chemically "marked" as distinct from oxaloacetate's carbons even though citrate itself looks superficially symmetric.
Go deeper · Derivation B · 2 minMechanism II — the two oxidative decarboxylations and substrate-level phosphorylation
Goal. Derive why oxidation of a hydroxyl group followed by decarboxylation is such a recurring biochemical motif, and show explicitly how succinyl-CoA synthetase converts thioester bond energy into a phosphoanhydride bond (GTP) via a phosphohistidine intermediate.
Step 1 (isocitrate dehydrogenase: oxidation). NAD⁺ (or NADP⁺ in the cytosolic isozyme) accepts a hydride from the secondary carbinol carbon of isocitrate. A base (often assisted by a divalent Mn²⁺ or Mg²⁺ ion coordinating the substrate's carboxylates) removes the O–H proton as the hydride transfers to NAD⁺'s nicotinamide ring, generating oxalosuccinate, a β-keto acid:
Step 2 (decarboxylation). Oxalosuccinate's β-keto arrangement (a carbonyl positioned β to a carboxylate) is primed for spontaneous decarboxylation: the carboxylate leaves as CO₂, and the electron pair left behind flows into the adjacent carbonyl system, generating an enol which tautomerizes to the ketone α-ketoglutarate. The metal ion (Mn²⁺/Mg²⁺) chelates the carbonyl oxygen and the departing carboxylate throughout, stabilizing the developing negative charge on the transition state — a textbook example of electrostatic catalysis lowering the decarboxylation barrier:
Note this releases the first CO₂ of the turn. This carbon originated from oxaloacetate, not from the entering acetyl group — a fact confirmed by classic ¹⁴C isotope-tracing experiments (Ogston / Wood era) and one of the reasons the "two carbons in equals two carbons out, same turn" intuition is chemically wrong even though it is numerically correct.
Step 3 (α-ketoglutarate dehydrogenase complex: analogous chemistry to PDH). The α-ketoglutarate dehydrogenase complex is structurally and mechanistically homologous to Pyruvate Dehydrogenase and Acetyl-CoA's multienzyme complex, using the same five cofactors (TPP, lipoamide, FAD, CoA, NAD⁺) in the same sequence:
Mechanistically: thiamine pyrophosphate's ylide carbon attacks the α-keto carbon, CO₂ departs (the second CO₂ of the turn, this time genuinely tracing back to the original acetyl-CoA methyl carbon from this turn), the resulting hydroxyethyl-TPP carbanion is oxidized by transfer to lipoamide's disulfide, forming a thioester-linked dihydrolipoamide-succinyl adduct, which then transfers the succinyl group to CoA-SH, and finally FAD/NAD⁺ reoxidize the dihydrolipoamide back to lipoamide for another round. This is why the two-carbon loss per turn, taken as a matched pair over successive turns, does correspond to the acetyl group eventually being fully oxidized, even though within any single turn the correspondence between "entering carbon" and "leaving carbon" is scrambled.
Step 4 (succinyl-CoA synthetase: substrate-level phosphorylation). Succinyl-CoA carries a high-energy thioester bond (ΔG°′ of hydrolysis around −33 kJ/mol, comparable to ATP's terminal phosphate). Succinyl-CoA synthetase couples this hydrolysis to phosphorylation of GDP (or ADP in some isozymes) via a three-step mechanism:
The enzyme's active-site phosphate first attacks the thioester carbonyl, displacing CoA-SH and forming a mixed carboxylic–phosphoric anhydride, succinyl phosphate — itself a high-energy compound.
The phosphoryl group is transferred to a specific active-site histidine's imidazole nitrogen, forming a phosphohistidine intermediate — this is the "substrate-level" step, chemically identical in principle to phosphoglycerate kinase or pyruvate kinase's substrate-level phosphorylations in glycolysis, except here the phosphoryl carrier is a histidine rather than staying enzyme-free in solution.
The phosphohistidine then transfers its phosphoryl group to GDP, forming GTP (nucleoside diphosphate kinase subsequently equilibrates GTP + ADP ⇌ GDP + ATP in tissues that need ATP directly, such as most non-hepatic, non-renal cells). This three-step relay conserves the succinyl-CoA thioester bond energy almost quantitatively as a new phosphoanhydride bond, illustrating the general principle that high-energy bonds are conserved as covalent phosphoryl-enzyme intermediates during transfer, not simply released as heat.
Worked examples
Example 1 — Foundational: carbon counting through one full turn. Track the carbons explicitly. Acetyl-CoA (2 carbons, call them a1–a2) condenses with oxaloacetate (4 carbons, o1–o4) to form citrate (6 carbons). Aconitase does not break or form any C–C bonds, only moves an OH, so isocitrate retains all six carbons in the same connectivity. Isocitrate dehydrogenase removes the carbon that was o2 or o3 (specifically, the carbon that carried the newly oxidized/decarboxylated carboxylate, traceable by classic labeling to one of the original oxaloacetate carbons) as the first CO₂, leaving α-ketoglutarate (5 carbons). α-Ketoglutarate dehydrogenase removes a second carbon as CO₂, leaving succinyl-CoA (4 carbons) — and by the symmetry of succinate's structure (see the trap discussion below), the succinyl-CoA's four carbons are chemically equivalent to a symmetric molecule, so the acetyl-derived carbons a1, a2 end up scrambled onto both "ends" of the eventual oxaloacetate with 50% probability each in the very next turn. Net result confirmed by counting: 6 carbons in (as citrate) minus 2 CO₂ equals 4 carbons out (as oxaloacetate), and separately 2 carbons entered as acetyl-CoA while 2 carbons left as CO₂ over the full cycle when tallied across enough turns — an asymmetric, non-trivial bookkeeping result, not a coincidence of matching indices.
Example 2 — Applied: energy yield from one acetyl-CoA using modern P/O ratios, worked with explicit non-round numbers. Suppose a tissue oxidizes 0.35 mmol of acetyl-CoA per minute fully through the cycle and electron transport chain. Per turn the cycle produces 3 NADH, 1 FADH₂, 1 GTP. Using P/O ratios of 2.5 ATP per NADH and 1.5 ATP per FADH₂ (values reflecting the actual measured stoichiometry of protons pumped per electron pair divided by the ~4 H⁺ needed per ATP via ATP synthase, rather than the older idealized integers):
So this tissue generates:
Cross-check with the earlier headline value: the "9.5 ATP equivalents" figure quoted for the general stoichiometric relationship used 2.5+2.5+2.5+1.5+1 = 9.5; the discrepancy here (10.0 vs 9.5) arises only from whether the GTP-to-ATP conversion itself is assumed cost-free (it is, via nucleoside diphosphate kinase, ΔG°′ near zero) — both figures are self-consistent once you check which convention is used; the correct minimal accounting per turn is 3(2.5) + 1(1.5) + 1 = 10.0 ATP equivalents, and this is the number that should be carried into full glucose-oxidation bookkeeping.
Example 3 — Exam/competition level: equilibrium consequence of citrate synthase's large negative ΔG°′ under altered mitochondrial [acetyl-CoA]/[CoA-SH] ratios. The actual (non-standard) ΔG for the citrate synthase reaction depends on the mitochondrial matrix concentrations of all four species:
Suppose matrix concentrations are measured (illustrative, asymmetric, non-round values) as [citrate] = 0.40 mM, [CoA-SH] = 0.060 mM, [oxaloacetate] = 0.0009 mM (oxaloacetate is normally scarce — its low steady-state concentration is itself a major control point), and [acetyl-CoA] = 0.070 mM, at 37°C (T = 310 K), with ΔG°′ = −31.5 kJ/mol.
Even with a 381-fold ratio of products to reactants (far from standard state, and specifically penalized by the very low oxaloacetate concentration in the denominator), the reaction remains substantially exergonic. This is the chemical reason oxaloacetate's scarcity does not stall the cycle under normal conditions — the intrinsic ΔG°′ is so favorable that citrate synthase runs forward across a wide range of physiological concentration ratios; only pathological or extreme metabolic states (e.g., severe reductive stress raising NADH/NAD⁺ and thus favoring malate over oxaloacetate at malate dehydrogenase, which is near equilibrium) push oxaloacetate low enough to become truly flux-limiting.
Limiting cases, scope & common traps
| Scenario | What actually happens | Common misconception |
|---|---|---|
| High [NADH]/[NAD⁺] ratio (e.g., fasting, β-oxidation active) | Malate dehydrogenase equilibrium shifts toward malate, lowering [oxaloacetate]; isocitrate DH and α-KG DH are allosterically/thermodynamically inhibited by high NADH | That the cycle simply "runs slower everywhere equally" — in fact specific near-equilibrium steps (malate DH) shift while irreversible steps (citrate synthase, IDH, αKGDH) are the actual control points |
| Tracing acetyl-CoA's carbons | The 2 carbons lost as CO₂ in a given turn are NOT the same 2 carbons that entered as acetyl-CoA in that same turn (see Worked Example 1) | Assuming the acetyl group's carbons are directly and immediately expelled as CO₂ in the same cycle |
| Succinate's fate | Succinate is symmetric (a dicarboxylic acid with a mirror plane), so succinate dehydrogenase's product, fumarate, cannot "remember" which succinyl-CoA carbon was which | Believing the cycle can stereochemically track which of succinate's two carboxyl-bearing carbons came from which precursor — it structurally cannot, since succinate has no chiral handle |
| Cycle as ATP factory only | The cycle is equally a biosynthetic hub: citrate exits to the cytosol for fatty acid synthesis, α-ketoglutarate is a nitrogen acceptor/donor (transamination to glutamate), oxaloacetate feeds gluconeogenesis and aspartate synthesis, succinyl-CoA feeds heme synthesis | Treating the "cycle" as a closed loop that never loses intermediates — it constantly does, which is exactly why Anaplerotic Reactions and Cycle Regulation exist to refill it |
| FADH₂ from succinate dehydrogenase | FADH₂ is covalently bound to the enzyme and passes electrons directly to ubiquinone within Complex II, never existing as a soluble diffusible species | Treating FADH₂ as if it diffuses to Complex I like NADH does — it does not; it enters the chain at a different point with a correspondingly lower ATP yield |
| Does the cycle require O₂ directly? | No step in the eight reactions uses O₂ as a substrate | Assuming citric acid cycle enzymes are themselves oxygen-consuming — O₂ is required only downstream, to regenerate NAD⁺/FAD by accepting electrons at Complex IV |
The chemist behind it
Hans Adolf Krebs (1900–1981) pieced together the cycle in 1937 while working in Sheffield, England, having fled Nazi Germany four years earlier after losing his university position under the 1933 Civil Service Law targeting Jewish academics. Krebs had trained under Otto Warburg, one of the most demanding and rigorous biochemists of the era, and he brought Warburg's manometric respiration assays (measuring O₂ uptake and CO₂ release from minced pigeon breast muscle, chosen for its extraordinarily high respiratory rate) to bear on a puzzle that had stumped Albert Szent-Györgyi and others: how do four-carbon dicarboxylic acids (succinate, fumarate, malate, oxaloacetate) catalytically accelerate respiration in tissue slices even when added in tiny, sub-stoichiometric amounts? Krebs's insight was that these compounds were not being consumed as fuel but were cycling — each converted into the next, ultimately regenerating the first, while a separate substrate (pyruvate, and later recognized as acetyl-CoA after Fritz Lipmann's 1945 discovery of coenzyme A) was continuously fed in and oxidized to CO₂. The original 1937 paper (submitted to Nature and initially rejected for being too long, then published in Enzymologia) proposed what was then called the citric acid cycle or tricarboxylic acid cycle, missing only the precise identity of the "active acetate" that Lipmann would later identify as acetyl-CoA. Krebs shared the 1953 Nobel Prize in Physiology or Medicine with Fritz Lipmann, a fitting pairing since Lipmann's coenzyme A work supplied the missing entry point that made Krebs's cycle mechanistically complete.
Origins · 1 minHans Adolf Krebs and how this was discovered
Krebs combined rigorous quantitative manometry with a chemist's instinct for cyclical, catalytic logic, and insisted throughout his career on meticulous, reproducible measurement — a discipline he credited directly to his early training under Otto Warburg.
Does the citric acid cycle directly require oxygen?
No single reaction among the eight uses molecular oxygen as a substrate. All the oxidations in the cycle transfer electrons to NAD⁺ or FAD, not to O₂ directly. The cycle is nonetheless strictly aerobic in practice because it depends on continuous regeneration of oxidized NAD⁺ and FAD; without functioning oxidative phosphorylation to reoxidize NADH and FADH₂ (which does require O₂ as the terminal electron acceptor at Complex IV), the NAD⁺/FAD pools become exhausted within seconds to minutes and the cycle stalls entirely, even though no individual step chemically needs O₂.
Why does citrate synthase's mechanism proceed via an enolate rather than simple nucleophilic addition of an unactivated methyl group?
An unactivated methyl carbon adjacent to a thioester carbonyl is not nucleophilic; it needs to be converted into a carbanion (enolate) first, since only a carbanion has the electron density to attack an electrophilic carbonyl carbon. The thioester's carbonyl group acidifies the adjacent C–H bonds by allowing the resulting negative charge to delocalize onto the carbonyl oxygen through resonance, lowering what would otherwise be a prohibitively high pKa (near 25 for an isolated methyl group) down to a range the enzyme's active-site base can deprotonate under physiological conditions.
Why is isocitrate dehydrogenase considered a major control point rather than an equilibrium-poised step?
Isocitrate dehydrogenase catalyzes an oxidative decarboxylation with a strongly negative ΔG°′, making it thermodynamically irreversible under cellular conditions, unlike malate dehydrogenase or aconitase, which operate close to equilibrium and can be pushed in either direction by mass action. Because the reaction is irreversible, its rate is set purely by enzyme activity and substrate/effector concentrations rather than by substrate/product ratios, which is precisely the kind of step evolution tends to select as a regulatory control point — allosterically activated by ADP and Ca²⁺, inhibited by ATP and NADH.
How does the cycle connect to amino acid metabolism?
Several cycle intermediates are direct precursors or products of amino acid metabolism, which is why the cycle is often drawn as a biosynthetic hub rather than a closed combustion loop. α-Ketoglutarate is reversibly transaminated to glutamate, linking the cycle directly to nitrogen assimilation and to the urea cycle. Oxaloacetate transaminates to aspartate. Succinyl-CoA is a direct precursor of heme biosynthesis (condensing with glycine via ALA synthase) and also receives carbon skeletons from the breakdown of valine, isoleucine, methionine, and threonine. This is why intermediates are constantly siphoned off, and why replenishing reactions (studied under Anaplerotic Reactions and Cycle Regulation) are essential rather than optional.
Why does succinate dehydrogenase use FAD rather than NAD⁺ as its electron acceptor?
The succinate-to-fumarate oxidation has a standard reduction potential for the substrate couple (E°′ around +0.031 V) that is too weakly reducing to transfer electrons efficiently to NAD⁺ (E°′ = −0.320 V) with a favorable driving force; the potential gap works out backward for that direction of electron flow. FAD's covalently tethered, membrane-embedded chemistry instead allows the enzyme to pass electrons almost directly into the ubiquinone pool at a matched redox potential, without needing to overcome that unfavorable gap, at the cost of entering the Electron-Transport Chain downstream of Complex I and therefore yielding less ATP per electron pair than NADH does.
What happens to the cycle's flux during intense exercise versus fasting?
During intense exercise, high ADP and Ca²⁺ (released with each muscle contraction) allosterically activate isocitrate dehydrogenase and pyruvate dehydrogenase, accelerating flux to match the sharply increased ATP demand, while pyruvate supply from glycolysis is abundant. During prolonged fasting, fatty acid oxidation dominates acetyl-CoA supply, and the resulting high NADH/NAD⁺ and acetyl-CoA/CoA-SH ratios instead inhibit pyruvate dehydrogenase and slow flux through the early cycle steps, favoring gluconeogenic withdrawal of oxaloacetate over its condensation with acetyl-CoA — part of why fasting shifts oxaloacetate toward glucose synthesis rather than cycle turnover.
Is the "citric acid cycle" the same thing as the "Krebs cycle" and "TCA cycle"?
Yes, all three names refer to the identical set of eight reactions; the terminology differences are purely historical and stylistic. "Citric acid cycle" and "tricarboxylic acid (TCA) cycle" both name it after the six-carbon tricarboxylic intermediate citrate that forms in the first step, while "Krebs cycle" honors Hans Krebs, who first proposed the cyclic scheme in 1937. Textbooks and research literature use all three interchangeably, and no distinction in chemistry or scope is implied by the choice of name.